Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
8 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
28 Mar 24
8-K/A
Submission of Matters to a Vote of Security Holders
22 Mar 24
8-K
Departure of Directors or Certain Officers
8 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
4 Jan 24
DEF 14A
Definitive proxy
7 Dec 23
PRE 14A
Preliminary proxy
5 Dec 23
8-K
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Departure of Directors or Certain Officers
17 Aug 23
8-K
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
10 Aug 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
8-K
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
15 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Regulation FD Disclosure
8 May 23
8-K
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
2 May 23
8-K
Predictive Oncology Announces Reverse Stock Split
20 Apr 23
DEFA14A
Additional proxy soliciting materials
17 Apr 23
8-K
Changes in Registrant's Certifying Accountant
5 Apr 23
DEF 14A
Definitive proxy
29 Mar 23
8-K
Predictive Oncology Reports Year End 2022 Financial Results and Provides Business Update
21 Mar 23
10-K
2022 FY
Annual report
21 Mar 23
PRE 14A
Preliminary proxy
17 Mar 23
8-K
Predictive Oncology Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
16 Mar 23
8-A12G
Registration of securities
16 Mar 23
8-K
Regulation FD Disclosure
14 Mar 23
8-K
Other Events
13 Mar 23
8-K
Other Events
3 Mar 23
8-K/A
Departure of Directors or Certain Officers
28 Feb 23
8-K
Predictive Oncology Appoints Pamela Bush, Ph.D., MBA, as Chief Business Officer
3 Feb 23
8-K
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
5 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
2 Dec 22
8-K
Predictive Oncology Reports Third Quarter Financial Results
10 Nov 22
10-Q
2022 Q3
Quarterly report
10 Nov 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10 Nov 22
8-K
David S. Smith appointed to the Board of Directors of Predictive Oncology
25 Oct 22
8-K
Predictive Oncology Announces New Chief Executive Officer Raymond F. Vennare to Lead Company Growth
20 Oct 22
DEFA14A
Additional proxy soliciting materials
18 Oct 22
DEF 14A
Definitive proxy
18 Oct 22
Latest ownership filings
4
CLAIR GREGORY SR ST.
12 Apr 24
4
Matthew Hawryluk
12 Apr 24
4
Veena Rao
12 Apr 24
4
Charles Lee Nuzum Sr
12 Apr 24
4
DANIEL E HANDLEY
12 Apr 24
4
NANCY CHUNG-WELCH
12 Apr 24
4
Veena Rao
4 Oct 23
4
DANIEL E HANDLEY
4 Oct 23
4
CLAIR GREGORY SR ST.
4 Oct 23
4
NANCY CHUNG-WELCH
4 Oct 23
4
Matthew Hawryluk
4 Oct 23
4
Charles Lee Nuzum Sr
4 Oct 23
4
ROBERT L MYERS
27 Sep 23
4
Charles Lee Nuzum Sr
27 Sep 23
4
Charles Lee Nuzum Sr
5 Jul 23
4
CLAIR GREGORY SR ST.
5 Jul 23
4
Veena Rao
5 Jul 23
4
Matthew Hawryluk
5 Jul 23
4
DANIEL E HANDLEY
5 Jul 23
4
NANCY CHUNG-WELCH
5 Jul 23
4
Veena Rao
12 May 23
3
Veena Rao
12 May 23
4
Matthew Hawryluk
5 Apr 23
4
CLAIR GREGORY SR ST.
5 Apr 23
4
NANCY CHUNG-WELCH
5 Apr 23
4
DANIEL E HANDLEY
5 Apr 23
4
Charles Lee Nuzum Sr
5 Apr 23
4
David Stewart Smith
5 Apr 23
3
Pamela Bush
10 Feb 23
4
Charles Lee Nuzum Sr
30 Jan 23
4
David Stewart Smith
5 Jan 23
4
DANIEL E HANDLEY
4 Jan 23
4
Raymond F Vennare
4 Jan 23
4
Matthew Hawryluk
4 Jan 23
4
CLAIR GREGORY SR ST.
4 Jan 23
4
NANCY CHUNG-WELCH
4 Jan 23
4
Charles Lee Nuzum Sr
4 Jan 23
4
DANIEL E HANDLEY
15 Dec 22
4
Matthew Hawryluk
5 Dec 22
3
Matthew Hawryluk
5 Dec 22